Multiple Sclerosis Center, Swedish Neuroscience Institute

Clinical research site in Seattle, Washington

As of July 2026, 1 paid clinical trial is recruiting at Multiple Sclerosis Center, Swedish Neuroscience Institute in Seattle, Washington. Active studies at this site cover conditions such as Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Multiple Sclerosis Center, Swedish Neuroscience Institute (1)

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

for Relapsing Multiple Sclerosis

20 locations incl. Palo Alto

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 18 - 55

Code: NCT04047628·Phase 3·Recruiting·Listed Aug 2019

Apply to this trial

More research sites in Seattle

Seattle Children's Hospital (192 trials)
University of Washington (186 trials)
Fred Hutchinson Cancer Center (142 trials)
Fred Hutch/University of Washington Cancer Consortium (104 trials)
Swedish Medical Center-First Hill (66 trials)
University of Washington Medical Center (48 trials)
Swedish Medical Center (41 trials)
University of Washington Medical Center - Montlake (38 trials)
Swedish Cancer Institute (37 trials)
Fred Hutchinson Cancer Research Center (36 trials)

Explore more

Paid clinical trials in Seattle, WA · Washington clinical trials